From

Institution

Field

Type

Open access only Cited by patents (Lens) Include non-Aachen papers (citing/cited)

Reset

Papers matching “ocular toxicity testing” 15

Sort: Relevance Cited Newest Oldest Fwci Patents ⇩ CSV

Not finding it? Sign in to also search OpenAlex live.

High-Frequency Application of Cationic Agents Containing Lubricant Eye Drops Causes Cumulative Corneal Toxicity in an Ex Vivo Eye Irritation Test Model
2020 Journal of Ocular Pharmacology and Therapeutics article Medicine Ocular Surface and Contact Lens

R Michael Dutescu, Daniel Uthoff, Claudia Panfil, Norbert Franz Schrage

11

citations
Impact of Latanoprost Antiglaucoma Eyedrops and Their Excipients on Toxicity and Healing Characteristics in the Ex Vivo Eye Irritation Test System
2023 Ophthalmology and Therapy article Medicine Drug-Induced Ocular Toxicity Open access

Claudia Panfil, Laure Chauchat, Camille Guerin, Hayette Rebika, Marwan Sahyoun, Norbert Franz Schrage

13

citations
Defining corneal chemical burns: A novel exact and adjustable ocular model
2021 Toxicology Reports article Medicine Corneal Surgery and Treatments Open access

Markus Glaudo, Claudia Panfil, Norbert Franz Schrage

3

citations
Unveiling the hidden risks of human exposure to nanomedicine and nanopollutants: Nanoparticle-induced blood barrier disruption and tissue toxicity
2025 Colloids and Surfaces B Biointerfaces article Materials Science Nanoparticles: synthesis and applications Open access

Mohammad-Hosein Fathian-Nasab, Mohammad Amin Manavi, Mohadeseh Gelivarisarshari, Seyed Mojtaba Daghighi, Cordian Beyer, Maryam Baeeri, +1 more

21

citations
Phase Ib/II trial testing combined radiofrequency ablation and ipilimumab in uveal melanoma (SECIRA-UM)
2020 Melanoma Research article Medicine Ocular Oncology and Treatments Open access

Elisa A. Rozeman, Warner Prevoo, Mark A. Meier, Karolina Sikorska, Trieu My Van, Bart A. van de Wiel, +12 more

53

citations
Ocular administration of brinzolamide leading to Stevens-Johnson syndrome/toxic epidermal necrolysis overlap: A case report and review
2025 Medicine article Medicine Drug-Induced Adverse Reactions Open access

Huayi Lu, Wenqiang Xu, Yali Wu, Mingrui Zhang, Sen Ma

2

citations
A Novel Ex Vivo Blinking Method for Comparing the Corneal Residence Time of New Shampoo Formulations
2024 Alternatives to Laboratory Animals article Medicine Ocular Surface and Contact Lens

Markus Glaudo, Marc Urbach, Claudia Panfil, Stephanie Herkert, Marc B. Brown, Norbert Franz Schrage

1

citations
A phase Ib trial of combined PKC and MEK inhibition with sotrastaurin and binimetinib in patients with metastatic uveal melanoma
2023 Frontiers in Oncology article Medicine Ocular Oncology and Treatments Open access

Sebastian Bauer, James Larkin, Frank Stephen Hodi, Frank Stephen, Ellen Kapiteijn, Gary K. Schwartz, +4 more

12

citations
Combining Hepatic Percutaneous Perfusion With Ipilimumab Plus Nivolumab In Advanced Uveal Melanoma (CHOPIN): Study Protocol For A Phase Ib/Randomized Phase II Trial.
2021 Research Square preprint Medicine Ocular Oncology and Treatments Open access

Thaïs M. L. Tong, Monique K. van der Kooij, Frank M. Speetjens, Arian R. van Erkel, Rutger W. van der Meer, Jacob Lutjeboer, +7 more

3

citations
Zebrafish eye development and function is affected by crude oil exposure – line of evidence from underlying molecular effects to behavioral consequences
2024 bioRxiv (Cold Spring Harbor Laboratory) preprint Environmental Science Environmental Toxicology and Ecotoxicology Open access

Leonie K. Mueller, Sarah Johann, Bernd Denecke, Ali Taleb Abdallah, Markus Hecker, Henner Hollert, +1 more

1

citations
TLD1433 Photosensitizer Inhibits Conjunctival Melanoma Cells in Zebrafish Ectopic and Orthotopic Tumour Models
2020 Cancers article Medicine Photodynamic Therapy Research Studies Open access

Quanchi Chen, Vadde Ramu, Yasmin Aydar, Arwin Groenewoud, Xue‐Quan Zhou, Martine Johanna Jager, +5 more

51

citations
Combining Hepatic Percutaneous Perfusion with Ipilimumab plus Nivolumab in advanced uveal melanoma (CHOPIN): study protocol for a phase Ib/randomized phase II trial
2022 Trials article Medicine Ocular Oncology and Treatments Open access

Thaïs M. L. Tong, Monique K. van der Kooij, Frank M. Speetjens, Arian R. van Erkel, Rutger W. van der Meer, Jacob Lutjeboer, +7 more

23

citations
Phase Ib/randomized phase II study combining hepatic percutaneous perfusion with ipilimumab plus nivolumab in advanced uveal melanoma: The CHOPIN trial.
2021 Journal of Clinical Oncology conference-abstract Medicine Ocular Oncology and Treatments

Thaïs M. L. Tong, Mark Christiaan Burgmans, Monique K. van der Kooij, Frank M. Speetjens, Arian R. van Erkel, Rutger W. van der Meer, +11 more

0

citations
A first-in-human study of DYP688, an antibody drug conjugate delivering a direct Gq/11 inhibitor, in patients with metastatic uveal melanoma (MUM) and other GNAQ/11 mutant melanomas.
2025 Journal of Clinical Oncology conference-abstract Medicine Ocular Oncology and Treatments Open access

Matteo Salvatore Carlino, Reinhard Dummer, Tanja Gromke, Jessica Cecile Hassel, Ellen Kapiteijn, Damien Kee, +12 more

6

citations
Safety and efficacy of combined melphalan percutaneous hepatic perfusion (M-PHP) and ipilimumab plus nivolumab (IPI+NIVO) in metastasized uveal melanoma (mUM): First results of the phase Ib part of the CHOPIN trial.
2022 Journal of Clinical Oncology conference-abstract Medicine Ocular Oncology and Treatments

Thaïs M. L. Tong, Mark Christiaan Burgmans, Frank M. Speetjens, Arian R. van Erkel, Rutger W. van der Meer, Carla S. P. van Rijswijk, +9 more

1

citations

15 results